These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2110990)

  • 1. Augmentation of glucocorticoid action on human monocytes by interleukin-4.
    Hart PH; Whitty GA; Burgess DR; Croatto M; Hamilton JA
    Lymphokine Res; 1990; 9(2):147-53. PubMed ID: 2110990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.
    Hart PH; Whitty GA; Piccoli DS; Hamilton JA
    Immunology; 1989 Mar; 66(3):376-83. PubMed ID: 2495247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins.
    Taupin V; Gogusev J; Descamps-Latscha B; Zavala F
    Mol Pharmacol; 1993 Jan; 43(1):64-9. PubMed ID: 8380885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages.
    Hart PH; Cooper RL; Finlay-Jones JJ
    Immunology; 1991 Mar; 72(3):344-9. PubMed ID: 2026443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
    Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
    J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production.
    Bonder CS; Dickensheets HL; Finlay-Jones JJ; Donnelly RP; Hart PH
    J Immunol; 1998 Apr; 160(8):4048-56. PubMed ID: 9558115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes.
    Caughey GE; Pouliot M; Cleland LG; James MJ
    J Immunol; 1997 Jan; 158(1):351-8. PubMed ID: 8977210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta.
    Schmidt M; Pauels HG; Lügering N; Lügering A; Domschke W; Kucharzik T
    J Immunol; 1999 Sep; 163(6):3484-90. PubMed ID: 10477621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
    Jovanovic DV; Di Battista JA; Martel-Pelletier J; Jolicoeur FC; He Y; Zhang M; Mineau F; Pelletier JP
    J Immunol; 1998 Apr; 160(7):3513-21. PubMed ID: 9531313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
    McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms.
    Zhang Y; McCluskey K; Fujii K; Wahl LM
    J Immunol; 1998 Sep; 161(6):3071-6. PubMed ID: 9743373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced glucocorticoid sensitivity of monocyte interleukin-6 release in male employees with high plasma levels of tumor necrosis factor-alpha.
    Wirtz PH; von Känel R; Kunz-Ebrecht S; Ehlert U; Fischer JE
    Life Sci; 2004 May; 75(1):1-10. PubMed ID: 15102517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.
    Pang L; Knox AJ
    Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.
    Amano Y; Lee SW; Allison AC
    Mol Pharmacol; 1993 Feb; 43(2):176-82. PubMed ID: 8429822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A; Ferrara P; Caput D
    Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases.
    Déage V; Burger D; Dayer JM
    Eur Cytokine Netw; 1998 Dec; 9(4):663-8. PubMed ID: 9889411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.